Filing Flows

Filing Flows › Iradimed (IRMD) › Recalls, complaints & regulation

Iradimed (IRMD): recalls

Iradimed (IRMD) beyond its filings: 0 recalls in the last 12 months (1 in five years, 0 Class I).

Latest recalls

Iradimed's latest quarter

Iradimed, Q3 2026: revenue $24.2M (+14% year over year), operating margin 33.6%, net earnings $6.5M, operating cash flow $7.0M. The chart follows the revenue to costs, profit and cash.

Questions

Has Iradimed had any recalls?

1 recall on file over five years from the FDA, CPSC and NHTSA; 0 in the last 12 months.

Open the interactive view →

Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.